There is more competition in play for Emgality from Lundbeck’s new intravenous ... in a clinic rather than by subcutaneous self-injection. Amgen reported $306 million from US sales of Aimovig ...

Emgality is available as a once-monthly, self-administered, subcutaneous injection, like Aimovig. Teva offers the option of a quarterly injection with Ajovy, as well as a monthly dosing schedule.

Menstrual migraine affects more than half of people with both periods and migraine. Find out what you can do to manage this ...

The U.S. Food and Drug Administration has approved a self-injection version of Vyvgart Hytrulo (efgartigimod alfa and ...

FDA approved Vyvgart Hytrulo prefilled syringe for gMG and CIDP self-injection in 20–30 seconds. Human factor studies showed patients and caregivers safely administered the new formulation.

The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa ...

“Today’s FDA approval provides a new self-injection option across both approved indications in the U.S. that is designed for patients who seek more independence with their treatment,” said ...

Schematic of the self-injection procedure. Scientists at the Massachusetts Institute of Technology (MIT) have devised a new type of injection to grant long-term protection from pregnancy without ...

The Food and Drug Administration (FDA) has approved a prefilled syringe formulation of Vyvgart ® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) that allows patients to self-inject the medication.

Argenx (ARGX) announced that the U.S. Food and Drug Administration approved a new option for patients to self-inject VYVGART Hytrulo with a prefilled syringe for the treatment of adult patients ...